ProVise Management Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-939
| Closed | -$267K | – | 336 |
|
|
2023
Q2 | $267K | Hold |
939
| – | – | 0.02% | 296 |
|
|
2023
Q1 | $261K | Hold |
939
| – | – | 0.03% | 298 |
|
|
2022
Q4 | $260K | Sell |
939
-561
| -37% | -$155K | 0.03% | 274 |
|
|
2022
Q3 | $401K | Hold |
1,500
| – | – | 0.04% | 224 |
|
|
2022
Q2 | $306K | Buy |
1,500
+488
| +48% | +$99.6K | 0.03% | 252 |
|
|
2022
Q1 | $213K | Buy |
+1,012
| New | +$213K | 0.02% | 349 |
|
|
2016
Q2 | – | Sell |
-900
| Closed | -$234K | – | 304 |
|
|
2016
Q1 | $234K | Sell |
900
-200
| -18% | -$52K | 0.05% | 252 |
|
|
2015
Q4 | $337K | Buy |
+1,100
| New | +$337K | 0.07% | 221 |
|
|
2014
Q2 | – | Sell |
-932
| Closed | -$285K | – | 310 |
|
|
2014
Q1 | $285K | Sell |
932
-245
| -21% | -$74.9K | 0.07% | 239 |
|
|
2013
Q4 | $329K | Buy |
1,177
+75
| +7% | +$21K | 0.08% | 223 |
|
|
2013
Q3 | $265K | Sell |
1,102
-20
| -2% | -$4.81K | 0.08% | 256 |
|
|
2013
Q2 | $241K | Buy |
+1,122
| New | +$241K | 0.07% | 273 |
|